HCA Healthcare (NYSE:HCA) Price Target Raised to $500.00

HCA Healthcare (NYSE:HCA) had its target price boosted by Oppenheimer from $400.00 to $500.00 in a report issued on Monday morning, Marketbeat reports. They currently have an outperform rating on the stock.

Several other equities analysts also recently commented on the stock. Weiss Ratings restated a “buy (b-)” rating on shares of HCA Healthcare in a research note on Wednesday, October 8th. Barclays boosted their target price on shares of HCA Healthcare from $390.00 to $445.00 and gave the stock an “overweight” rating in a research note on Thursday, September 18th. The Goldman Sachs Group began coverage on shares of HCA Healthcare in a research note on Tuesday, October 14th. They set a “buy” rating and a $470.00 target price for the company. Mizuho boosted their target price on shares of HCA Healthcare from $425.00 to $475.00 and gave the stock an “outperform” rating in a research note on Friday, October 17th. Finally, Wolfe Research downgraded shares of HCA Healthcare from an “outperform” rating to a “peer perform” rating in a research note on Monday, July 28th. Fourteen research analysts have rated the stock with a Buy rating and ten have given a Hold rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $473.53.

HCA Healthcare Stock Up 0.4%

Shares of NYSE HCA opened at $468.21 on Monday. The firm has a market cap of $109.56 billion, a price-to-earnings ratio of 18.10, a PEG ratio of 1.37 and a beta of 1.40. HCA Healthcare has a 52-week low of $289.98 and a 52-week high of $475.38. The business’s 50 day moving average is $418.76 and its two-hundred day moving average is $385.09.

HCA Healthcare (NYSE:HCA) last announced its earnings results on Friday, October 24th. The company reported $6.96 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $5.64 by $1.32. The company had revenue of $19.16 billion for the quarter, compared to analyst estimates of $18.55 billion. HCA Healthcare had a negative return on equity of 792.25% and a net margin of 8.53%.The firm’s quarterly revenue was up 9.6% compared to the same quarter last year. During the same quarter in the previous year, the company earned $4.90 earnings per share. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. Analysts anticipate that HCA Healthcare will post 24.98 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Monday, December 29th. Investors of record on Monday, December 15th will be given a $0.72 dividend. The ex-dividend date of this dividend is Monday, December 15th. This represents a $2.88 dividend on an annualized basis and a yield of 0.6%. HCA Healthcare’s payout ratio is 11.13%.

Insider Activity at HCA Healthcare

In other news, EVP Michael S. Cuffe sold 3,836 shares of the company’s stock in a transaction dated Monday, September 8th. The shares were sold at an average price of $418.84, for a total value of $1,606,670.24. Following the completion of the sale, the executive vice president directly owned 31,503 shares of the company’s stock, valued at approximately $13,194,716.52. This represents a 10.85% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 1.30% of the company’s stock.

Institutional Investors Weigh In On HCA Healthcare

Institutional investors and hedge funds have recently made changes to their positions in the business. Cheviot Value Management LLC purchased a new stake in shares of HCA Healthcare in the first quarter valued at about $26,000. Saudi Central Bank purchased a new stake in shares of HCA Healthcare in the first quarter valued at about $26,000. WPG Advisers LLC purchased a new position in HCA Healthcare during the first quarter worth about $27,000. Ameriflex Group Inc. purchased a new position in HCA Healthcare during the second quarter worth about $27,000. Finally, Chung Wu Investment Group LLC purchased a new position in HCA Healthcare during the second quarter worth about $27,000. 62.73% of the stock is owned by hedge funds and other institutional investors.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.